To be fair, Remdesivir is an under-patent medicine designed by an American company, it isn't all that outlandish that the USA would procure as much as possible.

To be fair, Remdesivir is an under-patent medicine designed by an American company, it isn't all that outlandish that the USA would procure as much as possible. The "among other things" is doing a _lot_ of heavy lifting in your statement. I do not see any evidence that the USA bought anything that would limit the ability for other countries to develop a vaccine. Only to use Remdesivir as a treatment. Which, I can see both sides of that really. I also don't have a problem with the USA targeting 300 mil doses through OWS. They simply mean they will buy that many, not that other countries can't buy more etc. As I said, the leading vaccine right now is from a British university and a Swedish/British company funded by the USA (in part). I think it is totally fair for the USA to make a large investment and "pre-order" 300 million doses. If they were ordering 600 million doses and demanding that the patent be transferred to a US company, that would be shady. But yeah, OWS is certainly part of Trump's re-election campaign. I despise Trump, and I hope OWS is successful well before November. If it gets him re-elected so be it. People are dying.